Kenza Health Hub logoGet Started
1 May 2026Potentially dangerous, obsolete, or ineffective

Metamizole Injectable: Dosing and Precautions

Metamizole injectable guidance for pain and fever, with serious agranulocytosis and anaphylaxis warnings.

Also searched as

Dipyrone injectableNoramidopyrine injectableMetamizole injectable
Prescription under medical supervision

Source reviewed

source date listed on the source page

Guide category

Potentially dangerous, obsolete, or ineffective

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Use restrictions

Given the potentially serious adverse effects and that safer alternatives exist, this drug should not be prescribed as first choice treatment.

Therapeutic action

Analgesic, antipyretic.

Indications

Pain, fever.

Forms and strengths, route of administration

1 g in 2 ml ampoule (500 mg/ml) for IM, SC or slow IV injection or infusion.

Dosage

Adult: 500 mg every 8 hours if necessary.

Duration

As short as possible.

Contra-indications, adverse effects, precautions

  • May cause severe agranulocytosis, potentially fatal, regardless of dose or duration of treatment.
  • May cause allergic reactions and anaphylactic shock.
  • Pregnancy: contraindicated.
  • Breast-feeding: contraindicated.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.